MPC-3100

CAT: 0804-HY-13301Size: 1 mgDry Ice: NoHazardous: No

CAT#:0804-HY-13301Size:1 mg

Selected

PRICE

AVAILABILITY: InStock

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

1 / 1

Description

MPC-3100 is an orally bioavailable, synthetic, second-generation small-molecule inhibitor of Hsp90 with potential antineoplastic activity[1].

CAS Number

[958025-66-6]

UNSPSC

12352005

Hazard Statement

H315, H319, H335

Target

HSP

Type

Reference compound

Related Pathways

Cell Cycle/DNA Damage; Metabolic Enzyme/Protease

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/mpc-3100.html

Purity

98.36

Solubility

DMSO : 5.5 mg/mL (ultrasonic; warming)

Smiles

NC1=C2C(N(CCC3CCN(C([C@@H](O)C)=O)CC3)C(SC4=C(Br)C=C(OCO5)C5=C4)=N2)=NC=N1

Molecular Formula

C22H25BrN6O4S

Molecular Weight

549.44

Precautions

H315, H319, H335

References & Citations

[1]Kim SH, et al. Discovery of (2S) -1-[4- (2-{6-amino-8-[ (6-bromo-1,3-benzodioxol-5-yl) sulfanyl]-9H-purin-9-yl}ethyl) piperidin-1-yl]-2-hydroxypropan-1-one (MPC-3100), a purine-based Hsp90 inhibitor. J Med Chem. 2012 Sep 13;55 (17) :7480-501.

Shipping Conditions

Blue Ice

Storage Conditions

-20°C, 3 years (Powder)

Scientific Category

Reference compound1

Clinical Information

Phase 1

Related Products

Catalog	Name
HY-162831	MPC-IN-1
HY-115499	MPC-0767
HY-R02989-01	Mmu-miR-3100-3p mimic
HY-R02990A-01	Mmu-miR-3100-5p agomir
HY-R02990-01	Mmu-miR-3100-5p mimic
HY-RI02990A-01	Mmu-miR-3100-5p antagomir
HY-RI02990-01	Mmu-miR-3100-5p inhibitor
HY-R02989A-01	Mmu-miR-3100-3p agomir
HY-RI02989A-01	Mmu-miR-3100-3p antagomir
HY-RI02989-01	Mmu-miR-3100-3p inhibitor

Alternative Products

Catalog	Name
A4063-5	MPC-3100
A11131-5	MPC-3100 5mg
A11131-50	MPC-3100 50mg
A11131-1	MPC-3100 1mg
A11131-100	MPC-3100 100mg
A11131-10	MPC-3100 10mg
A11131-25	MPC-3100 25mg
9479-10	MDV-3100
084961-01	MDV 3100
TRC-M199802-1MG	MDV 3100-d3

MPC-3100

Related Products

Alternative Products

Popular Products